Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Incidence and clinical relevance of anti–platelet...
Journal article

Incidence and clinical relevance of anti–platelet factor 4/heparin antibodies before cardiac surgery

Abstract

BACKGROUND: Heparin-induced thrombocytopenia (HIT) is caused by anti-platelet factor 4/heparin (PF4/H) immunoglobulin (Ig) G antibodies, which activate platelets. In some patients, anti-PF4/H antibodies are already detectable before cardiac surgery. Whether preoperative presence of antibodies confers adverse prognosis and which particular antibody classes (IgG, IgA, IgM) might be implicated are unknown. METHODS: We prospectively screened 591 …

Authors

Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert H-G; Warkentin TE; Greinacher A

Journal

American Heart Journal, Vol. 160, No. 2, pp. 362–369

Publisher

Elsevier

Publication Date

August 2010

DOI

10.1016/j.ahj.2010.05.026

ISSN

0002-8703